Work Experience:25 years experience in Internal medicine, cardiology and interventional cardiology and medical education. Awards from UAEU: Best Service, Best Teaching and Best clinical research. Professional Affiliations: Immediate Past President of Emirates Society of Cardiology, currently General Secretary Emirates Cardiac Society and Vice President of Gulf Intervention Society. Fellow of royal college of physicians UK, fellow American college of physician, fellow European society of cardiology, fellow of American college of cardiology, fellow American society of cardiac intervention and fellow of American heart association. Areas of Special Interest: Heart failure, Coronary artery disease, Dyslipidaemia, Hypertension, Arrhythmias, Cardiac intervention, Cardiac imaging, Screening for cardiac disease in sport players, Cardiovascular disease in pregnancy
Professor Shehab is a Chief editor of Emirates medical Journal and also service as editor in many other regional and international journals. Professor has published 156 paper in Medline.
Consultant none invasive cardiologist. Head of none invasive and echo department. MRCP (UK), FRCP (Edinburgh) National board of Echo (NBE) USA. Arab board of cardiology. Saudi Fellowship of cardiology. American board of CT coronary angio. Master degree of cardiology (ALEXANDRIA).
Dr. Alexandros Papachristidis qualified form Athens Medical School in Greece and completed a fellowship in echocardiography along with a PhD course at King’s College London. He was appointed as a Consultant Cardiologist at King’s College Hospital in 2018 and he has a leading role in the echocardiography department.
Fellowship Cleveland Clinic Foundation
Professor of Medicine university paris-cité
Former chairman working group interventional cardiology of European society of cardiology
Co-Founder EAPCI
Former chairman interventional cardiology Hôpital Européen Georges Pompidou
Founder of 2 startups: Arterial Remodeling Technologies and Scarcell Therapeutics
Director of Cardiac Catheterization Laboratories and Cardiovascular Research at the University Medical Center (UMC). Under his leadership, the Cardiology Fellowship program of UNLV Medicine at University Medical Center, Nevada Heart and Vascular Center and VA Medical Center has been started since July 1, 2014. Dr. Ahsan is the Director of this Cardiology Fellowship Program. He is in the editorial board of the journal of World Heart Federation, Global Heart.
Eric & Sheila Samson Endowed Chair in Cardiovascular Health
Director of Disease Management
Hoag Memorial Hospital Presbyterian,
Newport Beach, CA
Clinical Professor, University of California, Irvine
Past President, American College of Cardiology
Board Member, World Heart Federation
Prof. Grube is Professor of Medicine, Head, Center of Innovative Interventions in Cardiology (CIIC) University Hospital Bonn, Germany and Consulting Professor, Division of Cardiovascular Medicine, at Stanford University School of Medicine.
He received his first degree in Medicine at the Rheinische Friedrich-Wilhelm-University in Bonn. His cardiology training was completed at University of Wisconsin, Medical School and University of Bonn, Medical School.
He received his Board Certification in Internal Medicine, in Cardiology and in Angiology from the North Rhine Chamber of Medical Doctors and his post-doctoral lecturing qualification “Internal Medicine“ from the Rheinische Friedrich-Wilhelm-University in Bonn.
He is a fellow of the American College of Cardiology, the American College of Angiology and the Society for Cardiac Angiography & Interventions.
His research interest includes drug eluting stents, distal protection devices, debulking devices, restenosis and in-stent restenosis.
Dr. Emad Aziz is a Professor of Medicine and Section Chief of Cardiac Electrophysiology and Director of the Arrhythmia Institute at the Rutgers-NJMS University Hospital. Dr. Aziz is triple certified by the American Osteopathic Board of Internal Medicine, the American Osteopathic Board of Cardiology, and Cardiac Electrophysiology.
Dr. Aziz completed his residency training in Internal Medicine and fellowships in Cardiology and Clinical Cardiac Electrophysiology at St. Luke’s-Roosevelt Hospital Center, a University Hospital of Columbia University College of Physicians and Surgeons, along with a fellowship in Advanced Heart Failure at Montefiore-Einstein Heart Institute. He is a fellow of the American College of Cardiology and a fellow of the Heart Rhythm Society.
Since coming to NJMS, there has been significant growth of the electrophysiology department with the latest innovations in rhythm management now being offered in both in- and outpatient settings. The procedure volume of the EP lab has increased by over 400% compared to the prior year. Dr. Aziz has introduced new procedures not previously offered in the state of NJ, including the Impulse Dynamic implantation and Wise-CRT device, through the international SOLVE-CRT trial, for advanced heart failure. University Hospital is also the first site in the state to use the newly approved MICRA AV leadless pacemaker.
University Hospital will also be one of the first institutions in the country to offer Respicardia Remedē device for central sleep apnea. In addition to the SOLVE-CRT trial, Rutgers is also enrolled in two other clinical trials: MARVEN study sponsored through NIH looking at risk factors associated with ventricular tachyarrhythmias in non-ischemic cardiomyopathy and the SAF-ILR trial studying the safety and cost effectiveness of same day loop recorder implantation vs. traditional telemetry observation for patients with unexplained syncope.
Dr. Aziz is actively involved in education and established an EP rotation for residents and an EP curriculum for fellows, including weekly ECG rounds as well as fostering multiple active research projects. He has extensively published more than 170 abstracts, over 100 manuscripts, and book chapters in peer-reviewed and professional journals. Dr. Aziz has future endeavors that include developing an ACGME accredited Electrophysiology fellowship program, comprehensive atrial fibrillation and advanced ventricular tachycardia management programs as well as introducing stereotaxis GENESIS system for advanced robotic ablations.
Dr. Faisal Latif is a Clinical Associate Professor of Medicine at the University of Oklahoma, and Director of Cardiac Catheterization Laboratory at SSM Health St Anthony Hospital in Oklahoma City, OK. He completed fellowships in Cardiology at University of Oklahoma, followed by Interventional Cardiology at William Beaumont Hospital in Royal Oak, Michigan in USA.
Dr. Latif is the Chair of Quality Improvement Committee at SCAI and previously has served as the Governor of Oklahoma Chapter of the American College of Cardiology. He has authored over 40 peer-reviewed publications, associate editor of the book titled “Management of Complex Cardiovascular Problems”. His research interests include pre-operative cardiac evaluation before non-cardiac surgery, interventions of coronary CTOs, Peripheral vascular interventions particularly Carotid Stenting. He participates in quality initiatives through SCAI and ACC. In recognition of his research accomplishments, he was awarded Provost’s Research Award for 2015 by the University of Oklahoma.
Interventional cardiologist at Galeazzi-Sant’Ambrogio Hospital in Milan.
I trained in Trieste receiving my medical degree in 2007, and specifically in interventional cardiology at ISALA Hospital in Zwolle, De Netherlands. I have worked closely to Prof Antonio Colombo at San Raffaele Hospital in Milan for 5 years. From 2019 to 2022 I was chief of the interventional cardiology department at Maria Cecilia Hospital in Cotignola and coordinator of the educational program of 2nd level master in interventional cardiology at Ferrara University.
I have a strong interest in research and education. I have published 270 scientific articles in prestigious international scientific journals in the field of interventional cardiology.
Pediatric Cardiology at UC Davis Childrens’ Hospital, Fellow of the American College of Cardiology (FACC) and Master of Society of Cardiac Angiography and Interventions (MSCAI). He served as the chairman of the Congenital Heart Disease Council of the SCAI (2017-20) and as a member of the SCAI Board of Trustee (2019-22). He is also on the steering committee for Adult Congenital and Pediatric Cardiology (ACPC) section of the American College of Cardiology (ACC).
Professor of cardiology at Almeda Group And Oman International Hospital
Dr Ghaliah is also a Fellow of HeartRhythm Society(FHRS), Fellow of aEuropean Society of Cardiology (FESC),Member of European Heart Rhythm Association(EHRA) and board of trustees at the World Arrhythmia society.
She is well known international speaker in world class conferences, reviewer of Europaceand editorial board of JAFIB Journal. She is also on the advisoryboard of emerging new technologies.She was a winner of Cuore Sabina Award in Italy for great Professionality and Humanity in Cardiology.
Senior consultant Cardiologist, MD,MBA,FACP, FRCPC, FACC, started Medical school at the French Faculty Of Medicine(FFM) in Beirut then graduated from Paris University-France, did his Internship and started his Fellowship in Internal Medicine at Sherbrook University-Quebec-Canada, continued , trained and completed his Fellowship and Board Certification in Medicine and Adult Cardiology at” McGill University”. He detains an MBAIP from Sorbonne –Dauphine-USJ universities. He was Associate Cardiologist at The Montreal General Hospital-McGill University- and Chief Cardiology at “Centre Hospitalier De Lanaudière” affiliated teaching University Hospital in Quebec-Canada- and is an honorary member for life at the same hospital. Dr Kiwan was Principal Investigator and Investigator in many national Canadian and International studies .He continues to be involved in clinical research by being local and national PI of international studies in Lebanon. He detains an Award from Saudi Aramco for his services as Consultant Cardiologist and in Charge of the Non-invasive cardiology Lab where he introduced the stress echo and contrast echo technique. He is currently and since 2009 Chief of Medical Staff at “Bellevue University Medical Center” in Lebanon; a JCI accredited 170 beds hospitals. He is chief of Cardiology Division at BUMC and founding director of the BITC-Bellevue International Training Center /American Heart Association. He is Co-founder and current director of STRKE unit at BMC.He is the Chairman of the Non Invasive working group at the Lebanese Society of Cardiology (second mandate). He is a Co-Founder of the” Lebanese Chapter of the American College of Cardiology” and is currently Governor of this Chapter. Dr Kiwan has been and continues to be involved in many national and international conferences as a speaker, chairman, member of many scientific committees and co- organizer.
Medical Director of Cardiovascular Program Development for the MemorialCare Health System. In this role he serves as Clinical Professor and Director of Nuclear Cardiology Education at the UC Irvine. His research work is reflected in 200 publications. He served as the President of ASNC in 2007. Among his research contributions to the field are pioneering the addition of low-level exercise to various forms of pharmacologic stress and its use in COPD patients. Oxford University Press published the 6th edition of the textbook, authored by Dr. Thomas, Sam Wann and Myrvin Ellestad, Ellestad’s Stress Testing in 2019. Dr. Thomas received his undergraduate degree from the UC Irvine, his medical degree from UC San Francisco, and MPH from UC Berkeley. Medical residency was at the Massachusetts General Hospital with cardiology fellowship training at Cedars Sinai and the Massachusetts General.
Professor Habib Gamra obtained his medical degree from Sousse University School of Medicine (Tunisia) in 1987 before starting a residency in Cardiology at Charles Nicolle Hospital, Rouen (France) and a fellowship in interventional cardiology at the Good Samaritan Hospital and University of Southern California, Los Angeles, USA that he completed in 1993. He is currently professor in cardiology at the university of Monastir (Tunisia) since 1996 and he currently holds the following positions:
– Head of Cardiology A Department at Fattouma Bourguiba University Hospital – Monastir, Tunisia
– Chairman of the Pan African Course on Interventional Cardiology (PAFCIC) that is held annually since 2000 (www.pafcic.org)
– President of the Tunisian Heart Foundation
– Vice President North of The Panafrican Society of Cardiology (PASCAR)
– Director of Africa PCR
– Co-Director of CSI Africa congress
– Co-Chairman of Cardio Vascular Clinical Trialists MEMA meeting
– Co-Editor European Heart Journal for North Africa
– Past President of the working group on interventional cardiology of the Tunisian Society of Cardiology and Cardiovascular Surgery (GTCI)
– Past President of the African Heart Network
– Co-Chair of of The Panafrican Society of Cardiology (PASCAR) Interventional Cardiology Task Force (PASCI)
– Stent Save A Life country champion for Tunisia
– President of the regulatory specialised commission at the Tunisian ministry of health
He is also in the editorial board of various national and international journals.
Professor of Medicine at Mayo Clinic, chair for research of the divisions of structural heart disease and cardiovascular ultrasound. Director of intraoperative echocardiography. Valvular heart disease specialist.
Head of the Department of Electrophysiology and Senior Consultant at Ordensklinikum Linz, Austria. He has been actively working for the European Heart Rhythm Association (EHRA) since 2011 including a duty as Scientific Program Chair for the Annual Congress (6000 participants in 2017) and was elected in the Executive Board as Treasurer for 2018-2020. He served as the International Affairs Coordinator in the period 2020-2022. He is currently EHRA Executive Board Member and EHRA President Elect for 2022-2024.
MD in cardiology ( Imperial college London), completed higher Cardiology training and had his CCST in cardiology 2006, Consultant invasive cardiologist at Princess Alexandra Hospital and Essex Cardiothoracic centre, London.
Have multiple international publications and participate in multi international trials.
Currently Head of cardiac imaging at Princess Alexandra Hospital with special interest in advanced echo and pacemaker implant.
Head of Department of Adult Cardiac Surgery, Gottsegen National Cardiovascular Center Hungary
Head of the National Advisory Board for Cardiac Surgery of Hungary
Special interest: minimally invasive cardiac surgery, valve reconstructive surgery
Professor of Medicine at the University of Valencia
Researcher Emeritus, INCLIVA Research Institute, University of Valencia
Graduated in Medicine and PhD from the Medical School of the University of Valencia (1968-1974). Training in Internal Medicine and Fellowship in Nephrology and Hypertension by the Northwestern University, Chicago. From 2009 to 2017, Scientific Director of the Research Institute INCLIVA. President of the European Society of Hypertension (2011-2013). Associate Editor of Journal Hypertension. Awarded with the title of Doctor Honoris Causa by the University of Carol Davila, Bucharest and the Folkow Award in Research of the ESH.
Julia Grapsa has been a consultant cardiologist at Guy’s and St Thomas’ NHS Foundation Trust since March 2020. She leads the imaging team for tricuspid services.
She is also a Reader for King’s College London.
She is editor in chief for JACC Case Reports, under the American College of Cardiology.
She chairs the women in imaging task force under the European Association of Cardiovascular Imaging (EACVI), European Society of Cardiology (ESC). She is also a secretary (treasurer) for the ESC valvular heart disease council.
Consultant interventional adult congenital heart disease and Pediatric Cardiology, Prince sultan cardiac center, General secretary of Saudi Heart Association
Professor and Director of the 1st Department of Cardiology, University of Athens, Hippokration Hospital, Greece. Prof Tsioufis works as an interventional Cardiologist and Hypertension Specialist. He has special interest in cardiorenal disease, heart failure, hypertension, neuromodulation and peripheral arterial disease. He was a post-doctoral fellow at the Veterans Affairs Medical Centre, Georgetown University Washington DC, USA. He has more than 650 publications in peer-reviewed Journals, H-index> 60, more than 15000 citations. Member of the Task Force for the 2018 ESC/ESH hypertension guidelines. He has served as President of European Society of Hypertension (2017-19) and President of the Hellenic Society of Cardiology (2016-18).
Dr.Botros is Consultant of cardiac EP at Critical Care department, Cairo University and at Al Qassimi hospital UAE, Fellow of cardiac electrophysiology Asklepios klinik Hamburg-Germany. Dr.Botros is EHRA certified Electrophysiology Specialist and IBHRE Certified cardiac Device specialist. Member of German society of cardiology (DGK), Member of European Heart Rhythm Association (EHRA), Member of Egyptian society of cardiology (EgSC), Member of Egyptian Cardiac Arrhythmia Association (ECRA)
Dr. Botros practice include management of all cardiac rhythm abnormalities, catheter ablation and advanced Device therapy. Dr.Botros Research work includes published manuscripts and abstracts in the field of Afib and SVT, Reviewer of international journals and principle investigator of international research registries. He has lectured both nationally and internationally. He has been involoved in clinical teaching of EP fellows since 2015.
Dr Ebeid is a tenured Professor of Pediatrics (Cardiology) and Director of Pediatric Catheterization Laboratory at the University of Mississippi Medical Center. recognized nationally and internationally as a pioneer in the field of catheter intervention for complex congenital heart disease; receiving referrals and awards from within and outside the United States. He has been invited to multiple countries to perform and teach catheter interventions. Principal investigator for many devices. The first in his region to perform many cardiac interventions; authored multiple papers and book chapters; Presented live interventions before national and international audiences. He has been invited as a moderator, chair person, speaker, and faculty in many prominent international cardiac conferences
Professor and Chief, Pediatric Cardiology
James H. Nicholson Professor of Pediatrics
Medical Director, UCLA Children’s Heart Center
Director, UCLA Fetal Cardiology Program
Co-Director, UCLA Pediatric/Congenital Heart Program
UCLA Mattel Children’s Hospital
David Geffen School of Medicine at UCLA
Professor of Cardiology at Umea University, Sweden and Senior Consultant Cardiologist since 2008. Senior Lecturer and Consultant in Cardiology/ Echocardiography and Head of Royal Brompton Echo Department from 2001-2006.
Published over 430 papers, 5 text books and 15 chapters. Supervised 21 PhD and 100 MSc
Dr. Mirvat Alasnag is the Director of the Catheterization Laboratory at the King Fahd Armed Forces Hospital in Jeddah, Saudi Arabia. She was the first female interventional cardiologist in the Gulf region and has since represented women on multiple medical committees, including the Saudi Arabian Cardiac Interventional Society Board & the EAPCI Women’s Steering Committee. She is the current ACCWIC International Working Group Chair and a SCAI WIN member.
Dr. Alasnag trained in Clinical Cardiology and Interventional Cardiology at Loma Linda University Medical Center (Loma Linda, California) and Harper University Hospital, Detroit Medical Center (Detroit, Michigan), respectively. Since her graduation in 2009 to date, she has been a practicing Interventional Cardiologist at the King Fahd Armed Forces Hospital.
Dr. Alasnag is currently serving as a member of the Board of Trustees for SCAI and a member of the ACC Interventional Leadership Council. Dr. Alasnag is the Editor in Chief of Current Cardiovascular Imaging Reports. In addition, she is an Editor/Associate/Contributing Editor for JSCAI, Circulation: Cardiovascular Interventions, PCROnline, Open Heart, Radcliffe Cardiology, ACCEL, Faculty Opinions (ESC) and Cardiovascular Revascularization Medicine.
She is also a member of the ESC Congress Programme Committee, SCCT 2022 Program committee and EuroPCR Board. She is the Interventional Cardiology Section Chief of the Telemedicine Working Group and is an active on several other committees at ACC, SCAI, ESC, and SCCT.
Dr Mirvat Alasnag is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3) & US Cardiology in Review, Radcliffe Cardiology.
Professor Mohamed Abdel-Wahab is currently holding the position of Senior Consultant Cardiologist and Head of the Structural Heart Disease Department at the Leipzig Heart Center, and is a Professor of Interventional Cardiology at the University of Leipzig – Germany. The Leipzig Heart Center is one of the largest centers for cardiovascular disease management in Europe. He is leading clinical and research programs in the field of transcatheter valve replacement and complex coronary interventions. Before he moved to Leipzig, Abdel-Wahab was leading the coronary and structural heart disease program at the Heart Center of the Segeberger Kliniken in Bad Segeberg – Germany. He was presented the 2013 Publication Award of the Working Group on Interventional Cardiology of the German Society of Cardiology and the 2015 Andreas Grüntzig Award of the German Society of Cardiology. Professor Abdel-Wahab was a nucleus member of the Working Group on Interventional Cardiology of the German Society of Cardiology, and is a Fellow of the European Society of Cardiology, a member of several international academic boards, and has published more than 200 papers in the field of interventional cardiology in peer review journals.
Dr Mohamed Magdi is Head of Department of Electrophysiology (EP) at AL Qassimi Hospital in Sharjah, UAE, as well as Chairman and Director of Gulf EP Live international meeting. He is also Professor of Critical Care Cardiology and Electrophysiology at Cairo University in Egypt.
Dr Magdi obtained his Doctorate of Critical Care Cardiology and Electrophysiology at Cairo University Hospital in 2009. He was a Consultant and Fellow in the EP department at the University Hospital of Nancy, France from 2005 to 2007, where he performed over 1000 cases of ablation.
Dr Magdi is a member of the European Society of Cardiology, European Heart Rhythm Association, Egyptian Heart Rhythm Association and instructor at the American College of Trauma. He was the chair and presenter of several international meetings such as Cardiostim and Heart Rhythm Society meeting in 2016.
With a research interest in electroanatomic mapping and ablation, Dr Magdi has authored over 10 publications in international journals including the Journal of Interventional Cardiac Electrophysiology, Annales de Cardiologie et d’Angéiologie and Europace.
Consultant interventional cardiologist Ex-head of cardiology 2012-2018, Kuwait Heart Center Chest Diseases Hospital, Kuwait.
Mohammad Almutairi is a Consultant Interventional Cardiologist and Ex- Chairman of the Department of Cardiology in Chest Diseases Hospital. He obtained his MB, ChB with honour from Kuwait medical school, Kuwait University in 1997. He did his internship year in Farwaniya Hospital followed by a year serving as an assistant registrar in internal medicine.
He went to do an internal medicine residency program in McGill University in Montreal, Canada from 1999 to 2002. He then stayed at McGill University to complete a three years cardiology fellowship from 2002 to 2005 and one extra year of interventional fellowship mainly trained to be a specialist in catheterization via the radial approach.
Dr. Almutairi returned to Kuwait in July, 2006 and immediately joined the Cardiology Department in Chest Diseases Hospital. Since his return he made sure to establish the radial approach as the preferred approach for catheterization in Kuwait and now more than 85% of cases are done radially. He also completed level II training in multislice cardiac CT.
Dr. Almutairi has served as a speaker and/or panelist in several international meetings.
Dr. Almutairi is a member of Kuwait Cardiac Society, a fellow of the Gulf Heart Association,
a fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC), a fellow of the American college of Cardiology (FACC), a fellow of the Society for Cardiovascular Angiography and Interventions (FSCAI).
Dr. Almutairi served as the president of Kuwait Medical Association 2014-2018 , the president of Arab medical Medical union 2017-2018 and the president of Gulf Intervention Society 2017-2019
Senior Interventional Cardiologist and CEO of Procare Private hospital in Saudi Arabia, The Ex-president of the Saudi Arabian interventional cardiovascular society, experienced health care management between the governmental and private sectors in Saudi Arabia
Non interventional cardiology specialist in Khorfakan Hospital, a Emirate Health services facility, UAE, Head of Code blue service, and co-founder of heart failure program.
Clinical Director of Interventional Cardiology and Professor of Interventional Cardiology at the Thoraxcenter, Erasmus University Medical Center, Rotterdam. He obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent Fellowships in interventional cardiology at Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, United States and Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands, he joined the senior staff of the department of interventional cardiology in the Thoraxcenter in February 2010.
Professor Van Mieghem’s academic interest is in complex (calcified) coronary lesions, mechanical circulatory support and structural heart interventions. He obtained a PhD based upon his research in transcatheter valve therapies. Professor Van Mieghem is involved in the percutaneous coronary interventions and structural heart program.
Professor Van Mieghem has published and co-authored over 500 scientific papers in peer-reviewed journals. He is principle investigator and steering committee member in multiple ongoing international trials evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology and the American College of Cardiology.
Prof. Ori Ben received his medical degree magna cum laude from The Sackler School of Medicine. He completed his residency in internal medicine at New York University Medical Center/Bellevue Medical Center where he was also Chief Resident. He completed his cardiology training at the University of California, San Diego including a research fellowship in Atherosclerosis as a Merck/ACC Fellow and AHA Postdoctoral Research Fellow. He was chief fellow in Cardiology at UCSD before joining the faculty at UCSD in 1997.
He is Professor of Medicine at the University of California, San Diego (UCSD) where he is an active clinician and Director, Cardiovascular Outcomes Group (CVOG) at the Sulpizio Cardiovascular Institute. He also serves as the Chief Medical Officer for Bioventrix, Inc. developing new devices for heart failure.
Until 2011 Prof. Ben served as the Director of the Coronary Care Unit at UCSD Medical Center. He also served as the Deputy Editor of the Journal of the American College of Cardiology from 2002 through 2010. Dr. Ben-Yehuda is presently Editor-in-Chief of Coronary Artery Disease and Deputy Editor of Structural Heart: the Journal of the Heart Team, both peer reviewed journals. He is also the author and co-author of over 200 peer reviewed publications.
Prof Ben has extensive experience in clinical trial design, having served as Vice President, Cardiovascular Clinical Trials at Gilead Sciences from 2011-2013 and as the Executive Director of the Clinical Trials Center at the Cardiovascular Research Foundation (CRF) from 2013 to 2022.
Co-Editor for Eastern Europe, European Heart Journal
Vice-president, European Society of Cardiology (2020-2022)
President, Heart Failure Association of the ESC (2018-2020)
Academician, Serbian Academy of Sciences and Arts
Professor of Cardiology, University of Belgrade Faculty of Medicine and
Heart Failure Center, Belgrade University Medical Center
Dr. Aziz completed his pediatric cardiology fellowship at the Children’s Hospital of Philadelphia in 2010 and continued his training there in pediatric electrophysiology. During his fellowship, Dr. Aziz was awarded a training grant under the National Institute of Health (NIH) to investigate genotype and phenotype correlations in pediatric patients with long QT syndrome. Dr. Aziz also acquired skills in catheter ablation of pediatric arrhythmias and device (pacemaker and ICD) implantation. Following his fellowship, Dr. Aziz joined the Cleveland Clinic as a pediatric electrophysiologist. He is active in the training and teaching of medical students, residents and fellows, an activity that continuously inspires him. Dr. Aziz is also quite active in research and was the recent recipient of the SADS 2011 Young Investigator Award for his work on long QT syndrome.
Dr Aziz acquired skills in Catheter Ablation of pediatric arrhythmias and device implantation which is a regular part of his clinical practice. He is the director of the Inherited Arrhythmia Clinic and of Pediatric Sports Cardiology.
Head of the Department of Internal Medicine and Cardiology of University Hospital Brno and Medical Faculty of Masaryk University and President of the Czech Association of Interventional Cardiology. His working, research and educational activities have been mainly focused on interventional and acute cardiology. Since 2006 he has been part of the European Association of Interventional Cardiology (EAPCI) Committees. In 2012-2016 he was a member of EAPCI Executive Board and Chairman of the European Stent for Life Initiative. He has been a guarantee of the international Centre of Excellence program for complex PCI and intracoronary imaging and founder of the Czech TAVI Registry. He has published 213 peer-review articles with H-index 31.
Dr. Randall Thompson is an attending cardiologist at St. Luke’s Mid America Heart Institute in Kansas City and Professor of Medicine, University of Missouri – Kansas City. He earned his MD degree from Emory University School of Medicine in Atlanta before serving his Internal Medicine Residency and Cardiology Fellowship at Massachusetts General Hospital and Harvard Medical School. His clinical specialty includes nuclear cardiology and cardiovascular CT imaging. His research interests in recent years have focused on the search for the origins of atherosclerosis leading to CT scanning of ancient mummies and indigenous people living in remote locations.
Dr. Thompson is active in medical societies and currently serves as the Past-President of the American Society of Nuclear Cardiology as well as Chair of the American College of Cardiology Coding Work Group and is Cardiology Advisor to the AMA CPT Editorial Panel.
Research Scientist at the Texas Heart Institute, Houston, TX; 2009-current: Adjunct Assistant Professor at the University of Texas Medical School in Houston, Internal Medicine, Cardiology Division, Houston, TX; 2012 – ongoing: Cardiologist Medical Director, University Cardiology Division, “SS. Annunziata” Chieti Scalo Clinical Hospital; 2012 – 2019: expert in the subject in Diseases of the ‘Cardiovascular System at the University “G. D’Annunzio” Chieti-Pescara; 2009 – 2019: Contract Professor in Cardiovascular System Diseases at the Faculty of Dentistry, Degree Course in Dental Hygiene, University “G. D’Annunzio “Chieti-Pescara; 2012 – 2019: Contract Professor in Hemodynamics and Cardiovascular Therapy at the Faculty of Medicine and Surgery, Degree Course in Cardiocirculatory Perfusion, University “G. D’Annunzio “Chieti-Pescara; 2016: Contract Professor in Hemodynamics and Cardiovascular Therapy at the Faculty of Medicine and Surgery, Degree Course in Cardiocirculatory Perfusion, University of Brescia; 2012 – ongoing: Member of the Academic Board of the PhD course in Medical Biotechnology, University “G. d’Annunzio “of Chieti-Pescara; 2016 – 2019: Member and Professor of the School of Specialization in Cardiology, University” G. d’Annunzio “of Chieti-Pescara 2018-2019; Head of pulmonary arterial hypertension unit and consultant cardiologist, University Cardiology 1, Cisanello Hospital, Pisa (2019-present); Research Scientist, University of Pisa (2019-15/9/2022); Associate Professor in Cardiology, University of Pisa (16/9/2022-ongoing)
National scientific qualifications: Full Professor in Cardiology and in Sciences of the health professions and applied medical technologies; Associate Professor in Cardiology, Internal Medicine, Applied Biology, General and Clinical Pathology, Sciences of the health professions and applied medical technologies
Associate Professor Shibu Mathew is Head of Electrophysiology at the University of Essen.
He studied Medicine in Hamburg (Germany) and Cape Town(SA) and was trained in Mannheim and Hamburg (Germany). Shibu Mathew worked as Head of EP from 2019-2022 at the University of Giessen (Germany). He is an elected Board Member of the German National Arrhythmia Society (AGEP/DGK).
Dr. Helmy currently is a professor and chief of cardiology at Louisiana State University and co-director of the Heart and Vascular Institute at Ochsner-LSU Health Science Center, Shreveport, Louisiana.
Dr. Abdelaal is a pediatric cardiologist by training and served as the Medical Director of the Magdi Yacoub Aswan Heart Center (AHC) since its launch up to 2019. As of August of 2019, he moved to the USA to serve as the Medical Director at the Magdi Yacoub Global Heart Foundation USA. He graduated from Cairo University School of Medicine and participated in international fellowships at Boston Children’s Hospital, The Cleveland Clinic, and Harefield Hospital UK.
Dr. Wayne Batchelor currently serves as the Director or Interventional Cardiology, Director of Interventional Cardiology Research, Innovation and Education and Associate Director of the Inova Heart and Vascular Institute in Fairfax, VA. He is also an Adjunct Professor of Medicine at Duke University. Dr. Batchelor’s clinical and research interests span a broad range of complex structural heart and percutaneous coronary interventions (PCI), including transcatheter mitral valve repair/replacement, transcatheter aortic valve replacement (TAVR), percutaneous left atrial appendage closure and ASD/PFO closure. He has published over 200 peer-reviewed original abstracts/manuscripts, multiple book chapters and has participated in over 160 clinical trials, including serving as Principal Investigator in over 50 and has served on several national/international clinical trial steering committees. He recently served as National Co-Principal Investigator of the PLATINUM Diversity study, the first and only study to prospectively evaluate clinical outcomes in 1,501 minorities and women after coronary stent procedures across 52 U.S. sites and is currently National PI of the ALERT trial, a randomized trial evaluating the effectiveness of cardiac intelligence software in detecting undertreated aortic stenosis. Dr. Batchelor holds several leadership positions within national and international professional societies, including Chair of the American College of Cardiology’s (ACC) Interventional Sectional Leadership Council, Co-Chair of the NCDR STS/TVT Registry’s Steering Committee, Program Committee Member for the 2023 ACC/World Congress of Cardiology Scientific Sessions, and is a lifetime member of the Association of Black Cardiologists. He serves on the editorial boards of the Journal of the Society of Cardiovascular Angiography and Interventions and Cardiovascular Revascularization Medicine journals and has served as Guest-Editor on Journal of the American College of Cardiology. He is a special government employee and consultant to the U.S. Food and Drug Administration (FDA) within the Cardiovascular Devices Branch.
Prof. Hijazi is an interventional cardiologist who specializes in treating congenital and structural heart disease in both children and adults. He is a pioneer in the non-surgical repair of congenital and structural heart defects.
In 2007 Prof. Hijazi became the Director of the Rush Center for Congenital and Structural Heart Disease at Rush University Medical Center, Chicago and in 2010, he became the James A. Hunter, MD, University Chair. In January 2014, he became the inaugural chair of Pediatrics at Sidra Medicine and in April 2021 became the Chief Medical Officer.
On May 11, 2008, Prof. Hijazi became the 31st president of the Society for Cardiovascular Angiography and Interventions (SCAI), the major organization for interventional cardiologists that has more than 4,000 members worldwide.
On September, 2020, Professor Hijazi became the Founding President of a newly formed the PICS Society (Pediatric & Congenital Interventional Cardiovascular Society), the only Society that caters to the needs of pediatric and congenital interventional cardiologists as well as patients with congenital heart disease.
In 2011, Mayor Thomas Menino declared July 25, 2011 as the Ziyad M. Hijazi day in Boston, MA.
On March 23rd 2019 Dr. Hijazi was honored by the Ministry of Defense of Kuwait for his pioneering work helping children with congenital heart Disease in Kuwait and worldwide.
On November 30th, 2021 Dr. Hijazi was honored by the FIFA Arab World Cup as a migrating bird and his photo was displayed in the stadium.
